Short chain fatty acids (SCFAs) are the products of colonic bacterial degradation of unabsorbed starch and non-starch polysaccharide (fibre). They are important anions in the colonic lumen, affecting both colonocyte morphology and function. The three main acids (acetate, propionate, and butyrate) stimulate colonic sodium and fluid absorption and exert proliferative effects on the colonocyte. Experimental animal studies have shown that they promote adaptive responses to small intestinal resection and colonic anastomosis. Acetate increases colonic blood flow and enhances ileal motility. Butyrate has been shown to be the preferred energy substrate for the colonocyte and to be a potent differentiating agent in cell culture. Butyrate may also have a role in preventing certain types of colitis. A diet low in resistant starch and fibre, which will result in a low production of SCFAs in the colon, may explain the high occurrence of colonic disorders seen in the Western civilisation.
There is evidence that epithelia lining the intestinal tract rely more on luminal than on vascular energy supply. In the fed state, luminal glutamine and glucose are the main fuels for small intestinal epithelial cells. ' During starvation, endogenous sources (glutamine from muscle catabolism, ketone bodies from hepatic ketogenesis) can 
Propionate or butyrate, when tested singularly, did not augment motility. 15 In healthy volunteers intubated with multilumen catheters, a mixture of SCFAs (concentrations similar to those of colonic contents) instilled into the ileum produced more motor events than air or saline.'6 SCFAs also stimulated the colonic motility in vivo in the rat: propionate, n-butyrate, and n-valerate increased the contractile response of middle and distal, but not proximal, segments of the colon. '7 SCFAs have thus been shown to be associated with a motor response to coloileal reflux and may be regarded as components of a chemical reflux barrier. Their effect on the motility of various colonic segments is not well understood at present.
Effects of SCFAs on mucus release and celiular differentiation Infusion of SCFAs into the isolated rat caecum decreased the number of PAS (periodic acid Schiff reaction) positive cells, but was without effect in the more distal colon. 18 SCFAs, therefore, decrease the number of mucus storing cells, presumably by a local mechanism. Mucus released from these cells seems to contribute to a mucus layer between the luminal contents and the mucosa. This layer provides a microclimate, which differs from the luminal bulk phase in its physicochemical properties. This microclimate is pH constant and may play an important part in the absorption of protonated SCFAs.6 Differentiation and proliferation of the colonic mucosa are reviewed together as these two factors are interdependent. The 
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Effects of SCFAs on intestinal cell proliferation In many animal studies the feeding of dietary fibre or starch stimulated colonic cell proliferation. 25 This effect was absent in germ free rats showing that bacterial carbohydrate fermentation was necessary as a factor in raising cell turnover.26 SCFAs -that is, end products of fermentation -were subsequently identified as the causative agents: the infusion of SCFAs into the rat colon raised parameters of mucosal cellularity (mucosal weight, protein, RNA, DNA) significantly. The magnitude of effect was similar with butyrate alone as with a combination of SCFAs (acetate+propionate+ butyrate). 27 In vitro studies with normal human caecal biopsy specimens showed that SCFAs stimulated cell proliferation in the basal 60% of the crypts -that is, the physiological proliferative compartment: butyrate (10 mmol/l), propionate (25 mmol/l), and the SCFA mixture (acetate 60 mmol/l, propionate 25 mmolIl, butyrate 10 mmol/l) had a similar effect on DNA labelling, while the effect of acetate (60 mmol/l) was significantly smaller. 28 Thus, there is evidence that SCFAs have a trophic effect on the normal colonic mucosa. This may be important in relation to parenteral and enteral nutrition as there are data that mucosal atrophy occurs after a few days of bowel rest.29 To avoid epithelial atrophy and, possibly, bacterial translocation from the gut lumen to the circulation, the addition of fermentable fibre to liquid formula diets may be helpful.30
SCFAs in experimental postoperative conditions Increasing evidence that the colonic mucosa preferentially uses SCFAs as respiratory fuels has prompted investigators to study the possible effects of intracolonic SCFA infusions on the injured colon. In a rat model, transection and anastomosis of the descending colon was performed, and SCFAs were infused through a catheter placed proximal to the anastomosis. The anastomotic bursting pressure was significantly higher in animals receiving a SCFA mixture (acetate+propionate+buty-rate) than in the control group (electrolyte infusion).31 In a rat model of the short bowel syndrome (80% small bowel resection) the addition of pectin (a non-starch polysaccharide degraded to SCFA in the colon) to a fibre free chemically defined elemental diet increased parameters of mucosal cellularity (mucosal mass, DNA, RNA, and protein content) in the remaining ileum and colon. This was associated with a diminished weight loss compared with control animals fed the same diet without added pectin.32 In the same model, supplementation of total parenteral nutrition with SCFAs increased mucosal weight and DNA content in the jejunum and ileum without affecting nutritional parameters (body weight, nitrogen balance). There was, however, no significant effect of added SCFAs on the colonic mucosal parameters. 33 SCFAs and colitis The hypothesis has been put forward that a lack of luminal SCFAs leads, in the short term, to mucosal atrophy and, in the long term, to 'nutritional colitis'.4 This is especially evident in diversion colitis, which develops after complete diversion of the faecal stream and subsides after restoration of colorectal continuity.34 In four patients with diversion colitis SCFA irrigation (acetate 60, propionate 30, and butyrate 40 mmol/l) for two to three weeks resulted in macroscopic and histological resolution of inflammation.35 As decreased faecal concentrations of SCFAs have also been shown to occur in patients with ulcerative colitis36 SCFA enemas have been used to treat acute distal inflammation. Rectal irrigation with a SCFA mixture was effective in reducing the degree of inflammation after a six week treatment period (uncontrolled trial).37 In another placebo controlled study butyrate enemas (100 mmol/l) were used instead of the SCFA mixture, because the evidence was strongest for butyrate to affect the colonic mucosa3: after two weeks of treatment butyrate ameliorated acute inflammation judged by macroscopic and histological criteria, whereas no change was seen under placebo conditions.38
